Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dystrophia Myotonica”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06693037
What this trial is testing

Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant Therapy

Who this might be right for
HER2-positive Breast Cancer
Shu Wang 2,092
Early research (Phase 1)Study completedNCT02251457
What this trial is testing

Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1

Who this might be right for
Myotonia CongenitaParamyotonia CongenitaMyotonic Dystrophy 1
Ohio State University 35
Not applicableStudy completedNCT01136330
What this trial is testing

DM1 Heart Registry - DM1 Respiratory Registry

Who this might be right for
Myotonic Dystrophy
Institut de Myologie, France 914
Not applicableLooking for participantsNCT06747884
What this trial is testing

Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension

Who this might be right for
Congenital Myotonic DystrophyChildhood Myotonic DystrophyMyotonic Dystrophy
Virginia Commonwealth University 200
Not applicableUnknownNCT03155594
What this trial is testing

CGM to Aid Transition From Inpatient to Outpatient

Who this might be right for
Diabete Mellitus
Methodist Medical Center of Illinois 15
Testing effectiveness (Phase 2)Study completedNCT00509769
What this trial is testing

Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 112
Not applicableStudy completedNCT02375087
What this trial is testing

Sleep Breathing Disorders, a Main Trigger for Cardiac ARythmias in Type I Myotonic Dystrophy ?

Who this might be right for
Myotonic Dystrophy
University Hospital, Grenoble 73
Testing effectiveness (Phase 2)Looking for participantsNCT06300307
What this trial is testing

Study of ATX-01 in Participants With DM1

Who this might be right for
Myotonic Dystrophy 1
ARTHEx Biotech S.L. 56
Not applicableUnknownNCT06378216
What this trial is testing

Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]

Who this might be right for
Myotonic Dystrophy 1
IRCCS Eugenio Medea 30
Testing effectiveness (Phase 2)Looking for participantsNCT07220603
What this trial is testing

An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)

Who this might be right for
Myotonic Dystrophy 1
PepGen Inc 48
Testing effectiveness (Phase 2)Study completedNCT00875979
What this trial is testing

Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 67
Large-scale testing (Phase 3)UnknownNCT05848830
What this trial is testing

Home-based Training and Supplementation in DM1 Patients

Who this might be right for
Myotonic Dystrophy 1
McMaster University 60
Not applicableLooking for participantsNCT07136844
What this trial is testing

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Who this might be right for
Neuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more
Centre Hospitalier Universitaire de Liege 300
Not applicableLooking for participantsNCT05224778
What this trial is testing

DMCRN-02-001: Assessing Pediatric Endpoints in DM1

Who this might be right for
Congenital Myotonic DystrophyCDM
Virginia Commonwealth University 50
Not applicableStudy completedNCT04634682
What this trial is testing

Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Myogem Health Company, S.L. 30
Testing effectiveness (Phase 2)Looking for participantsNCT06667453
What this trial is testing

A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
PepGen Inc 24
Not applicableActive Not RecruitingNCT05889988
What this trial is testing

Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients

Who this might be right for
Breast Neoplasm
Mayo Clinic 36
Not applicableStudy completedNCT05006924
What this trial is testing

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Oslo University Hospital 89
Not applicableStudy completedNCT04018820
What this trial is testing

Effects of a 12-week Strength Training Program in Men With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Élise Duchesne 11
Early research (Phase 1)Study completedNCT02562378
What this trial is testing

T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
MedSIR 15
Next Page